Diabetics who need to switch from oral medications to insulin could reduce their annual healthcare costs up to $17,000 by using an insulin pen instead of a syringe to deliver their daily dose of medication.

Bones are typically thought of as calcified, inert structures, but researchers at Columbia University Medical Center have now identified a surprising and critically important novel function of the skeleton. They’ve shown for the first time that the skeleton is an endocrine organ that helps control our sugar metabolism and weight and, as such, is a major determinant of the development of type 2 diabetes.

High-quality long-term studies are lacking -- Not all studies have been fully published
There is currently no evidence available of a superiority of rapid-acting insulin analogues over human insulin in the treatment of adult patients with diabetes mellitus type 1.

A fat-derived protein known for its effects on the liver and might also serve as an energy-conserving signal to the brain during periods of starvation, suggests a new study in the July issue of Cell Metabolism, a publication of Cell Press.

Compounds found in pumpkin could potentially replace or at least drastically reduce the daily insulin injections that so many diabetics currently have to endure. Recent research reveals that pumpkin extract promotes regeneration of damaged pancreatic cells in diabetic rats, boosting levels of insulin-producing beta cells and insulin in the blood, reports Lisa Richards in Chemistry & Industry, the magazine of the SCI.

Orexigen(TM) Therapeutics Reports that data is to be presented on June 23rd at the American Diabetes Association 67th Scientific Sessions in Chicago.

Like many teenage girls, Lee Ann Thill had obsession with her appearance. A diabetic, she was already suffering from bulimia - tried to lose weight. But it was not enough, and she recently had put on 20 pounds (9 kilograms).

Half of Managed Care Pharmacy Directors Say they Will Not Cover Inhaled Insulin on their Formulary on the Basis of Improved Compliance Alone, According to a New Report from Decision Resources

A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published tomorrow (18 May) in the Journal of Biological Chemistry. The researchers hope that their findings will enable the development of new therapies for diabetes, a condition caused by insufficient levels of insulin.

By co-transplanting Sertoli cells together with insulin-producing cells into diabetic rats, his recent research demonstrated that insulin-producing cells can survive and can protect the rats against diabetes. By substituting the Sertoli cells from adult pigs, instead of those from baby pigs, Dr. White may have made a medical research breakthrough.